ACI Files Comments with the FTC Regarding PBM Business Practices and their Impact on Drug Prices BySteve Pociask April 20, 2022April 20, 2022
ACI Sends a Letter to Congress on Reducing Patient Drug Prices BySteve Pociask September 10, 2021September 10, 2021
Town Hall: Level the Playing Field for Drug Companies and Patients ByFoday Turay June 29, 2021June 29, 2021
Inside Sources: Biden Administration Should Continue Closing PBM Loopholes ByDerek Hosford January 28, 2021January 28, 2021
“Most Favored Nation” Scheme May Lower Prices, But It Won’t Help Medicare Beneficiaries ByKrisztina Pusok and Edward Longe December 2, 2020February 7, 2023
The Hill: Rx Middlemen Cost American Consumers Billions Each Year ByOliver McPherson-Smith February 3, 2020June 3, 2022
